Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Mycobacterium leprae | Probable 4-aminobutyrate aminotransferase GabT (GAMMA-AMINO-N-BUTYRATE TRANSAMINASE) (GABA TRANSAMINASE) (GLUTAMATE:SUCCINIC SEM | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 437 aa | 397 aa | 28.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0473 | 0.0686 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0137 | 0.0198 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0184 | 0.6095 | 1 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0184 | 0.6095 | 1 |
Echinococcus granulosus | Aminotransferase class III | 0.0026 | 0.0094 | 0.0136 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.8677 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.2551 | 0.2862 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0057 | 0.1258 | 0.1823 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0473 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0057 | 0.1258 | 0.1823 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0184 | 0.6095 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1062 | 0.1174 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0026 | 0.0094 | 0.0136 |
Brugia malayi | hypothetical protein | 0.0148 | 0.4737 | 0.541 |
Echinococcus multilocularis | Aminotransferase class III | 0.0026 | 0.0094 | 0.0136 |
Schistosoma mansoni | ornithine--oxo-acid transaminase | 0.0026 | 0.0094 | 0.0136 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.8677 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.1258 | 0.1401 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.6897 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.2011 | 0.2916 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0753 | 0.1091 |
Mycobacterium ulcerans | hypothetical protein | 0.0184 | 0.6095 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0049 | 0.0071 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0026 | 0.0094 | 0.5 |
Plasmodium falciparum | ornithine aminotransferase | 0.0026 | 0.0094 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.2354 | 0.2672 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0422 | 0.0612 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0473 | 0.0442 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 1 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1847 | 0.2677 |
Echinococcus granulosus | ornithine aminotransferase | 0.0026 | 0.0094 | 0.0136 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0245 | 0.0177 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0473 | 0.0686 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0473 | 0.0686 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.4737 | 0.5434 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0473 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0026 | 0.0094 | 0.0136 |
Echinococcus multilocularis | geminin | 0.0205 | 0.6897 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0137 | 0.0198 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0137 | 0.0198 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0753 | 0.1091 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.4737 | 0.4476 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.6897 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.4737 | 0.5434 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0865 | 0.0946 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0026 | 0.0094 | 0.5 |
Echinococcus granulosus | geminin | 0.0205 | 0.6897 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0862 | 0.0895 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.4737 | 0.4476 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0057 | 0.1258 | 0.1823 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1847 | 0.2677 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0057 | 0.1258 | 0.1823 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0184 | 0.6095 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0974 | 0.1072 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | 10.45 uM | PubChem BioAssay. Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.3753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (binding) | 100 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.